Oncostatin M causes VEGF release from human airway smooth muscle: Synergy with IL-1β

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 288, Issue 6 32-6, 2005, Pages

  Faffe, Débora S ^a,b   Flynt, Lesley ^a   Mellema, Matthew ^a   Whitehead, Timothy R ^a   Bourgeois, Kerri ^a,b,c   Panettieri Jr , Reynold A ^c   Silverman, Eric S ^a   Shore, Stephanie A ^a  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Interleukin 1 receptor 1; Interleukin 6; Monocyte chemoattractant protein 1; Piceatannol; Signal transducer and activator of transcription 3; Vascular endothelial growth factor

Indexed keywords

ANGIOGENIC FACTOR; CARDIOTROPHIN 1; CILIARY NEUROTROPHIC FACTOR; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 1BETA; INTERLEUKIN 6; LEUKEMIA INHIBITORY FACTOR; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; ONCOSTATIN M; PICEATANNOL; STAT3 PROTEIN; VASCULOTROPIN;

ARTICLE; BREATHING MUSCLE; CYTOKINE RELEASE; DRUG EFFECT; DRUG RELEASE; HUMAN; HUMAN TISSUE; MEDIATOR RELEASE; PLEIOTROPY; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN FAMILY; REAL TIME POLYMERASE CHAIN REACTION; RESPIRATORY EPITHELIUM; RNA STABILITY; SMOOTH MUSCLE FIBER; TRANSCRIPTION REGULATION;

CELLS, CULTURED; CHEMOKINE CCL2; DNA-BINDING PROTEINS; DRUG SYNERGISM; ENZYME INHIBITORS; GROWTH INHIBITORS; HUMANS; INFLAMMATION MEDIATORS; INTERLEUKIN-1; INTERLEUKIN-6; LUNG; MITOGEN-ACTIVATED PROTEIN KINASES; MUSCLE, SMOOTH; ONCOSTATIN M; PEPTIDES; PHOSPHORYLATION; PROTEIN-TYROSINE KINASES; RECEPTORS, INTERLEUKIN-1; RECEPTORS, INTERLEUKIN-1 TYPE I; RNA, MESSENGER; SIGNAL TRANSDUCTION; STAT3 TRANSCRIPTION FACTOR; STILBENES; TRANS-ACTIVATORS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 18844447702     PISSN: 10400605     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajplung.00333.2004     Document Type: Article

References (61)

1. Asai K, Kanazawa H, Otani K, Shiraishi S, Hirata K, and Yoshikawa J. Imbalance between vascular endothelial growth factor and endostatin levels in induced sputum from asthmatic subjects. J Allergy Clin Immunol 110: 571-575, 2002.
2. Barton BE, Karras JG, Murphy TF, Barton A, and Huang HF. Signal transducer and activator of transcription 3 activation in prostate cancer: direct STAT3 inhibition induces apoptosis in prostate cancer lines. Mol Cancer Ther 3: 11-20, 2004.
3. Bennett BL, Sasaki DT, Murray BW, O'Leary EC, Sakata ST, Xu W, Leisten JC, Motiwala A, Pierce S, Satoh Y, Bhagwat SS, Manning AM, and Anderson DW. SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase. Proc Natl Acad Sci USA 98: 13681-13686, 2001.
4. Bernard C, Merval R, Lebret M, Delerive P, Dusanter-Fourt I, Lehoux S, Creminon C, Staels B, Maclouf J, and Tedgui A. Oncostatin M induces interleukin-6 and cyclooxygenase-2 expression in human vascular smooth muscle cells: synergy with interleukin-1β. Circ Res 85: 1124-1131, 1999.
5. Boesiger J, Tsai M, Maurer M, Yamaguchi M, Brown LF, Claffey KP, Dvorak HF, and Galli SJ. Mast cells can secrete vascular permeability factor/vascular endothelial cell growth factor and exhibit enhanced release after immunoglobulin E-dependent upregulation of fc epsilon receptor I expression. J Exp Med 188: 1135-1145, 1998.
6. Boulay ME and Boulet LP. Airway response to low-dose allergen exposure in allergic nonasthmatic and asthmatic subjects: eosinophils, fibronectin, and vascular endothelial growth factor. Chest 123: 430S, 2003.
7. Boussat S, Eddahibi S, Coste A, Fataccioli V, Gouge M, Housset B, Adnot S, and Maitre B. Expression and regulation of vascular endothelial growth factor in human pulmonary epithelial cells. Am J Physiol Lung Cell Mol Physiol 279: L371-L378, 2000.
8. Brown TJ, Rowe JM, Liu JW, and Shoyab M. Regulation of IL-6 expression by oncostatin M. J Immunol 147: 2175-2180, 1991.
9. Cuenda A, Rouse J, Doza YN, Meier R, Cohen P, Gallagher TF, Young PR, and Lee JC. SB 203580 is a specific inhibitor of a MAP kinase homologue which is stimulated by cellular stresses and interleukin-1. FEBS Lett 364: 229-233, 1995.
10. Elias JA, Wu Y, Zheng T, and Panettieri R. Cytokine- and virus-stimulated airway smooth muscle cells produce IL-11 and other IL-6-type cytokines. Am J Physiol Lung Cell Mol Physiol 273: L648-L655, 1997.
11. Faffe DS, Flynt L, Mellema M, Moore PE, Silverman ES, Subramaniam V, Jones MR, Mizgerd JP, Whitehead T, Panettieri RAJ, and Shore SA. Oncostatin M causes eotaxin-1 release from airway smooth muscle: synergy with IL-4 and IL-13. J Allergy Clin Immunol. In press.
12. Favata MF, Horiuchi KY, Manos EJ, Daulerio AJ, Stradley DA, Feeser WS, Van Dyk DE, Pitts WJ, Earl RA, Hobbs F, Copeland RA, Magolda RL, Scherle PA, and Trzaskos JM. Identification of a novel inhibitor of mitogen-activated protein kinase kinase. J Biol Chem 273: 18623-18632, 1998.
13. Fehrenbach H, Kasper M, Haase M, Schuh D, and Muller M. Differential immunolocalization of VEGF in rat and human adult lung, and in experimental rat lung fibrosis: light, fluorescence, and electron microscopy. Anat Rec 254: 61-73, 1999.
14. Funamoto M, Fujio Y, Kunisada K, Negoro S, Tone E, Osugi T, Hirota H, Izumi M, Yoshizaki K, Walsh K, Kishimoto T, and Yamauchi-Takihara K. Signal transducer and activator of transcription 3 is required for glycoprotein 130-mediated induction of vascular endothelial growth factor in cardiac myocytes. J Biol Chem 275: 10561-10566, 2000.
15. Grove RI, Eberhardt C, Abid S, Mazzucco C, Liu J, Kiener P, Todaro G, and Shoyab M. Oncostatin M is a mitogen for rabbit vascular smooth muscle cells. Proc Natl Acad Sci USA 90: 823-827, 1993.
16. Gu L, Tseng S, Horner RM, Tam C, Loda M, and Rollins BJ. Control of TH2 polarization by the chemokine monocyte chemoattractant protein-1. Nature 404: 407-411, 2000.
17. Heinrich PC, Behrmann I, Haan S, Hermanns HM, Muller-Newen G, and Schaper F. Principles of interleukin-6-type cytokine signalling and its regulation. Biochem J 374: 1-20, 2003.
18. Hermanns HM, Radtke S, Schaper F, Heinrich PC, and Behrmann I. Non-redundant signal transduction of interleukin-6-type cytokines. The adapter protein She is specifically recruited to rhe oncostatin M receptor. J Biol Chem 275: 40742-40748, 2000.
19. Hoshino M, Nakamura Y, and Hamid QA. Gene expression of vascular endothelial growth factor and its receptors and angiogenesis in bronchial asthma. J Allergy Clin Immunol 107: 1034-1038, 2001.
20. Hui W, Bell M, and Carroll G. Detection of oncostatin M in synovial fluid from patients with rheumatoid arthritis. Ann Rheum Dis 56: 184-187, 1997.
21. Hurst SM, McLoughlin RM, Monslow J, Owens S, Morgan L, Fuller GM, Topley N, and Jones SA. Secretion of oncostatin M by infiltrating neutrophils: regulation of IL-6 and chemokine expression in human mesothelial cells. J Immunol 169: 5244-5251, 2002.
22. Jeffery PK. Remodeling in asthma and chronic obstructive lung disease. Am J Respir Crit Care Med 164: S28-S38, 2001.
23. Jung YD, Liu W, Reinmuth N, Ahmad SA, Fan F, Gallick GE, and Ellis LM. Vascular endothelial growth factor is upregulated by interleukin-1β in human vascular smooth muscle cells via the P38 mitogen-activated protein kinase pathway. Angiogenesis 4: 155-162, 2001.
24. Kazi AS, Lotfi S, Goncharova EA, Tliba O, Amrani Y, Krymskaya VP, and Lazaar AL. Vascular endothelial growth factor-induced secretion of fibronectin is ERK dependent. Am J Physiol Lung Cell Mol Physiol 286: L539-L545, 2004.
25. Knight DA, Lydell CP, Zhou D, Weir TD, Robert Schellenberg R, and Bai TR. Leukemia inhibitory factor and LIF receptor in human lung. Distribution and regulation of LIF release. Am J Respir Cell Mol Biol 20: 834-841, 1999.
26. Knox AJ, Corbett L, Stocks J, Holland E, Zhu YM, and Pang L. Human airway smooth muscle cells secrete vascular endothelial growth factor: upregulation by bradykinin via a protein kinase C and prostanoid-dependent mechanism. FASEB J 15: 2480-2488, 2001.
27. Lahiri T, Laporte JD, Moore PE, Panettieri RA Jr, and Shore SA. Interleukin-6 family cytokines: signaling and effects in human airway smooth muscle cells. Am J Physiol Lung Cell Mol Physiol 280: L1225-L1232, 2001.
28. Lahiri T, Moore PE, Baraldo S, Whitehead TR, McKenna MD, Panettieri RA Jr, and Shore SA. Effect of IL-1β on CRE-dependent gene expression in human airway smooth muscle cells. Am J Physiol Lung Cell Mol Physiol 283: L1239-L1246, 2002.
29. Langdon C, Kerr C, Hassen M, Hara T, Arsenault AL, and Richards CD. Murine oncostatin M stimulates mouse synovial fibroblasts in vitro and induces inflammation and destruction in mouse joints in vivo. Am J Pathol 157: 1187-1196, 2000.
30. Langdon C, Kerr C, Tong L, and Richards CD. Oncostatin M regulates eotaxin expression in fibroblasts and eosinophilic inflammation in C57BL/6 mice. J Immunol 170: 548-555, 2003.
31. Langdon C, Leith J, Smith F, and Richards CD. Oncostatin M stimulates monocyte chemoattractant protein-1- and interleukin-1-induced matrix metalloproteinase-1 production by human synovial fibroblasts in vitro. Arthritis Rheum 40: 2139-2146, 1997.
32. Laporte JD, Moore PE, Abraham JH, Maksym GN, Fabry B, Panettieri RA Jr, and Shore SA. Role of ERK MAP kinases in responses of cultured human airway smooth muscle cells to IL-1β. Am J Physiol Lung Cell Mol Physiol 277: L943-L951, 1999.
33. Laporte JD, Moore PE, Lahiri T, Schwartzman IN, Panettieri RA Jr, and Shore SA. P38 MAP kinase regulates IL-1β responses in cultured airway smooth muscle cells. Am J Physiol Lung Cell Mol Physiol 279: L932-L941, 2000.
34. Lee CG, Link H, Baluk P, Homer RJ, Chapoval S, Bhandari V, Kang MJ, Cohn L, Kim YK, McDonald DM, and Elias JA. Vascular endothelial growth factor induces remodeling and enhances TH2-mediated sensitization and inflammation in the lung. Nat Med 10: 1095-1103, 2004.
35. Lee YC, Kwak YG, and Song CH. Contribution of vascular endothelial growth factor to airway hyperresponsiveness and inflammation in a murine model of toluene diisocyanate-induced asthma. J Immunol 168: 3595-3600, 2002.
36. Levy AP, Levy NS, and Goldberg MA. Hypoxia-inducible protein binding to vascular endothelial growth factor mRNA and its modulation by the von Hippel-Lindau protein. J Biol Chem 271: 25492-25497, 1996.
37. Lin SK, Kok SH, Yeh FT, Kuo MY, Lin CC, Wang CC, Goldring SR, and Hong CY. MEK/ERK and signal transducer and activator of transcription signaling pathways modulate oncostatin M-stimulated CCL2 expression in human osteoblasts through a common transcription factor. Arthritis Rheum 50: 785-793, 2004.
38. Malik N, Kallestad JC, Gunderson NL, Austin SD, Neubauer MG, Ochs V, Marquardt H, Zarling JM, Shoyab M, Wei CM, Linsley PS, and Rose TM. Molecular cloning, sequence analysis, and functional expression of a novel growth regulator, oncostatin M. Mol Cell Biol 9: 2847-2853, 1989.
39. Mellema MS, Fredberg J, Panettieri R, and Shore SA. LIF signaling and HSP27 phosphorylation in cultured human airway smooth muscle cells. Am J Respir Crit Care Med 165: A346, 2002.
40. Modur V, Feldbaus MJ, Weyrich AS, Jicha DL, Prescott SM, Zimmerman GA, and McIntyre TM. Oncostatin M is a proinflammatory mediator. In vivo effects correlate with endothelial cell expression of inflammatory cytokines and adhesion molecules. J Clin Invest 100: 158-168, 1997.
41. Niu G, Wright KL, Huang M, Song L, Haura E, Turkson J, Zhang S, Wang T, Sinibaldi D, Coppola D, Heller R, Ellis LM, Karras J, Bromberg J, Pardoll D, Jove R, and Yu H. Constitutive Stat3 activity upregulates VEGF expression and tumor angiogenesis. Oncogene 21: 2000-2008, 2002.
42. O'Hara KA, Kedda MA, Thompson PJ, and Knight DA. Oncostatin M: an interleukin-6-like cytokine relevant to airway remodelling and the pathogenesis of asthma. Clin Exp Allergy 33: 1026-1032, 2003.
43. Oliver JM, Burg DL, Wilson BS, McLaughlin JL, and Geahlen RL. Inhibition of mast cell Fc epsilon R1-mediated signaling and effector function by the Syk-selective inhibitor, piceatannol. J Biol Chem 269: 29697-29703, 1994.
44. Panettieri RA, Murray RK, DePalo LR, Yadvish PA, and Kotlikoff MI. A human airway smooth muscle cell line that retains physiological responsiveness. Am J Physiol Cell Physiol 256: C329-C335, 1989.
45. 2 is a novel inducer of oncostatin-M expression in macrophages and microglia. J Neurosci 22: 5334-5343, 2002.
46. Repovic P, Fears CY, Gladson CL, and Benveniste EN. Oncostatin-M induction of vascular endothelial growth factor expression in astroglioma cells. Oncogene 22: 8117-8124, 2003.
47. 2 and cyclooxygenase-2 in astrocytes: synergy with interleukin-1β, tumor necrosis factor-α, and bacterial lipopolysaccharide. Glia 42: 433-446, 2003.
48. Rose CE Jr, Sung SS, and Fu SM. Significant involvement of CCL2 (MCP-1) in inflammatory disorders of the lung. Microcirculation 10: 273-288, 2003.
49. Ruprecht K, Kuhlmann T, Seif F, Hummel V, Kruse N, Bruck W, and Rieckmann P. Effects of oncostatin M on human cerebral endothelial cells and expression in inflammatory brain lesions. J Neuropathol Exp Neurol 60: 1087-1098, 2001.
50. Schuringa JJ, Schepers H, Vellenga E, and Kruijer W. Ser727-dependent transcriptional activation by association of p300 with STAT3 upon IL-6 stimulation. FEBS Lett 495: 71-76, 2001.
51. Stein I, Neeman M, Shweiki D, Itin A, and Keshet E. Stabilization of vascular endothelial growth factor mRNA by hypoxia and hypoglycemia and coregulation with other ischemia-induced genes. Mol Cell Biol 15: 5363-5368, 1995.
52. Su L and David M. Distinct mechanisms of STAT phosphorylation via the interferon-α/β receptor. Selective inhibition of STAT3 and STAT5 by piceatannol. J Biol Chem 275: 12661-12666, 2000.
53. Tanaka T, Kanai H, Sekiguchi K, Aihara Y, Yokoyama T, Arai M, Kanda T, Nagai R, and Kurabayashi M. Induction of VEGF gene transcription by IL-1β is mediated through stress-activated MAP kinases and Sp1 sites in cardiac myocytes. J Mol Cell Cardiol 32: 1955-1967, 2000.
54. Tischer E, Mitchell R, Hartman T, Silva M, Gospodarowicz D, Fiddes JC, and Abraham JA. The human gene for vascular endothelial growth factor. Multiple protein forms are encoded through alternative exon splicing. J Biol Chem 266: 11947-11954, 1991.
55. Vasse M, Pourtau J, Trochon V, Muraine M, Vannier JP, Lu H, Soria J, and Soria C. Oncostatin M induces angiogenesis in vitro and in vivo. Arterioscler Thromb Vasc Biol 19: 1835-1842, 1999.
56. Watson ML, Grix SP, Jordan NJ, Place GA, Dodd S, Leithead J, Poll CT, Yoshimura T, and Westwick J. Interleukin 8 and monocyte chemoattractant protein 1 production by cultured human airway smooth muscle cells. Cytokine 10: 346-352, 1998.
57. Wei D, Le X, Zheng L, Wang L, Frey JA, Gao AC, Peng Z, Huang S, Xiong HQ, Abbruzzese JL, and Xie K. Stat3 activation regulates the expression of vascular endothelial growth factor and human pancreatic cancer angiogenesis and metastasis. Oncogene 22: 319-329, 2003.
58. Wei LH, Kuo ML, Chen CA, Chou CH, Lai KB, Lee CN, and Hsieh CY. Interleukin-6 promotes cervical tumor growth by VEGF-dependent angiogenesis via a STAT3 pathway. Oncogene 22: 1517-1527, 2003.
59. Weiss TW, Speidl WS, Kaun C, Rega G, Springer C, Macfelda K, Losert UM, Grant SL, Marro ML, Rhodes AD, Fuernkranz A, Bialy J, Ullrich R, Holzmann P, Pacher R, Maurer G, Huber K, and Wojta J. Glycoprotein 130 ligand oncostatin-M induces expression of vascular endothelial growth factor in human adult cardiac myocytes. Cardiovasc Res 59: 628-638, 2003.
60. Wen FQ, Liu X, Manda W, Terasaki Y, Kobayashi T, Abe S, Fang Q, Ertl R, Manouilova L, and Rennard SI. TH2 cytokine-enhanced and TGF-β-enhanced vascular endothelial growth factor production by cultured human airway smooth muscle cells is attenuated by IFN-γ and corticosteroids. J Allergy Clin Immunol 111: 1307-1318, 2003.
61. Wierenga AT, Vogelzang I, Eggen BJ, and Vellenga E. Erythropoietin- induced serine 727 phosphorylation of STAT3 in erythroid cells is mediated by a MEK-, ERK-, and MSK1-dependent pathway. Exp Hematol 31: 398-405, 2003.